HiPSC-RPE cells
JSPH-iPSCs-RPE-001
Phase 2 mab active
Quick answer
HiPSC-RPE cells for AMD - Age-Related Macular Degeneration is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- AMD - Age-Related Macular Degeneration
- Phase
- Phase 2
- Modality
- mab
- Status
- active